Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of brugada syndrome

Journal of the American College of Cardiology

Volumn 63, Issue 19, 2014, Pages 2037-2045

  Szél, Tamás ^a,b   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

cardiac arrhythmias; electrophysiology; pharmacology

Indexed keywords

CILOSTAZOL; MILRINONE; NS 5806; POTASSIUM DERIVATIVE; QUINIDINE; UNCLASSIFIED DRUG; VERAPAMIL;

ACTION POTENTIAL; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUGADA SYNDROME; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; ECG ABNORMALITY; ENDOCARDIUM; EPICARDIUM; FEMALE; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REPOLARIZATION; WEDGE RESECTION; ELECTROCARDIOGRAM; ELECTROGRAPHY; FRACTIONATED ELECTROGRAM; LATE POTENTIAL ELECTROGRAM; MONGREL DOG;

CARDIAC ARRHYTHMIAS; ELECTROPHYSIOLOGY; PHARMACOLOGY;

ACTION POTENTIALS; ANIMALS; BRUGADA SYNDROME; DISEASE MODELS, ANIMAL; DOGS; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; MALE; PERICARDIUM;

EID: 84900542677     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.067     Document Type: Article

References (38)

1. P. Brugada, and J. Brugada Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report J Am Coll Cardiol 20 1992 1391 1396
2. G.X. Yan, and C. Antzelevitch Cellular basis for the electrocardiographic J wave Circulation 93 1996 372 379
3. C. Antzelevitch Brugada syndrome Pacing Clin Electrophysiol 29 2006 1130 1159
4. R. Brugada, J. Brugada, and C. Antzelevitch et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts Circulation 101 2000 510 515
5. E. Delpón, J.M. Cordeiro, and L. Núñez et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome Circ Arrhythm Electrophysiol 1 2008 209 218
6. J.R. Giudicessi, D. Ye, and C.J. Kritzberger et al. Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death Hum Mutat 33 2012 989 997
7. G.X. Yan, and C. Antzelevitch Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation Circulation 100 1999 1660 1666
8. S. Nagase, K.F. Kusano, and H. Morita et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead J Am Coll Cardiol 39 2002 1992 1995
9. K. Nosaka, H. Morita, and N. Nishii et al. Detection of conduction abnormality within QRS complex and risk stratification by wavelet transform of SAECG in Brugada syndrome Heart Rhythm 6 2009 S179
10. H. Tatsumi, M. Takagi, and E. Nakagawa et al. Risk stratification in patients with Brugada syndrome: analysis of daily fluctuations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG) J Cardiovasc Electrophysiol 17 2006 705 711
11. K. Nademanee, G. Veerakul, and P. Chandanamattha et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium Circulation 123 2011 1270 1279
12. F. Sacher, L. Jesel, and P. Jais et al. Insight into the mechanism of Brugada syndrome: epicardial substrate and modification during ajmaline testing Heart Rhythm 11 2014 732 734
13. J.M. Fish, D.R. Welchons, and Y.S. Kim et al. Dimethyl lithospermate B, an extract of danshen, suppresses arrhythmogenesis associated with the Brugada syndrome Circulation 113 2006 1393 1400
14. J.M. Di Diego, S. Sicouri, and R.C. Myles et al. Optical and electrical recordings from isolated coronary-perfused ventricular wedge preparations J Mol Cell Cardiol 54 2013 53 64
15. K. Calloe, J.M. Cordeiro, and J.M. Di Diego et al. A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome Cardiovasc Res 81 2009 686 694
16. H. Barajas-Martinez, D. Hu, and R. Pfeiffer et al. Loss-of-function cardiac L-type calcium channel mutation identifies CACNA2D1 as a new Brugada syndrome susceptibility gene Heart Rhythm 8 2011 S105
17. K. Yodogawa, N. Morita, and Y. Kobayashi et al. High-frequency potentials developed in wavelet-transformed electrocardiogram as a novel indicator for detecting Brugada syndrome Heart Rhythm 3 2006 1436 1444
18. H. Watanabe, M. Chinushi, and A. Osaki et al. Elimination of late potentials by quinidine in a patient with Brugada syndrome J Electrocardiol 39 2006 63 66
19. C. Antzelevitch, G.D. Pollevick, and J.M. Cordeiro et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death Circulation 115 2007 442 449
20. Q. Chen, G.E. Kirsch, and D. Zhang et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation Nature 392 1998 293 296
21. H. Watanabe, T.T. Koopmann, and S. Le Scouarnec et al. Sodium channel b1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans J Clin Invest 118 2008 2260 2268
22. + current and causes inherited arrhythmias Circulation 116 2007 2260 2268
23. E. Burashnikov, R. Pfeiffer, and H. Barajas-Martinez et al. Mutations in the cardiac L-type calcium channel associated J wave syndrome and sudden cardiac death Heart Rhythm 7 2010 1872 1882
24. D. Hu, H. Barajas-Martinez, and A. Medeiros-Domingo et al. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents Heart Rhythm 9 2012 760 769
25. T. Nakajima, J. Wu, and Y. Kaneko et al. KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram Circ J 76 2012 2763 2772
26. T. Kurita, W. Shimizu, and M. Inagaki et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome J Am Coll Cardiol 40 2002 330 334
27. C. Antzelevitch, P. Brugada, and J. Brugada et al. Brugada syndrome: a decade of progress Circ Res 91 2002 1114 1119
28. B. Belhassen, and S. Viskin Pharmacologic approach to therapy of Brugada syndrome: quinidine as an alternative to ICD therapy? C. Antzelevitch, P. Brugada, J. Brugada, The Brugada Syndrome: From Bench to Bedside 2004 Blackwell Futura Oxford, UK 202 211
29. B. Belhassen, A. Glick, and S. Viskin Efficacy of quinidine in high-risk patients with Brugada syndrome Circulation 110 2004 1731 1737
30. B. Belhassen Is quinidine the ideal drug for Brugada syndrome? Heart Rhythm 9 2012 2001 2002
31. S. Viskin, A.A. Wilde, and H.L. Tan et al. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry Heart Rhythm 6 2009 401 404
32. W. Shimizu, T. Aiba, and C. Antzelevitch Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome Curr Pharm Des 11 2005 1561 1572
33. G.S. Xiao, and Y.H. Liao Effect of cilostazol on transient outward potassium current in human atrial myocytes Zhongguo Ying Yong Sheng Li Xue Za Zhi 20 2004 238 241
34. B. Belhassen, S. Viskin, and R. Fish et al. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome J Cardiovasc Electrophysiol 10 1999 1301 1312
35. N. Kanlop, K. Shinlapawittayatorn, and R. Sungnoon et al. Cilostazol attenuates ventricular arrhythmia induction and improves defibrillation efficacy in swine Can J Physiol Pharmacol 88 2010 422 428
36. T. Szel, I. Koncz, and C. Antzelevitch Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome Heart Rhythm 10 2013 1720 1727
37. T. Tsuchiya, K. Ashikaga, and T. Honda et al. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome J Cardiovasc Electrophysiol 13 2002 698 701
38. J.M. Di Diego, J.M. Cordeiro, and R.J. Goodrow et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males Circulation 106 2002 2004 2011